D
Dermata Therapeutics, Inc. (DRMA)
NCM – Real Time Price. Currency in USD
1.24
+0.02 (1.64%)
At close: May 12, 2026, 4:00 PM EDT
1.24
0.00 (0.00%)
After-hours: May 12, 2026, 4:04 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.24
+0.02 (1.64%)
At close: May 12, 2026, 4:00 PM EDT
1.24
0.00 (0.00%)
After-hours: May 12, 2026, 4:04 PM EDT
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
| Name | Position |
|---|---|
| Dr. Christopher J. Nardo M.P.H., Ph.D. | Senior VP & Chief Development Officer |
| Dr. Maria Bedoya Toro Munera M.B.A., Ph.D. | Senior Vice President of Regulatory Affairs & Quality Assurance |
| Mr. David F. Hale | Co-Founder & Lead Independent Director |
| Mr. Gerald T. Proehl | Founder, President, CEO & Chairman |
| Mr. Sean Proehl | Associate General Counsel |
| Ms. Kyra Peckaitis | Vice President of Marketing |
| Ms. Kyri K. Van Hoose CPA, M.B.A. | Senior VP & CFO |
| Date | Type | Document |
|---|---|---|
| 2026-04-17 | DEFA14A | formdefa14a.htm |
| 2026-04-17 | DEF 14A | formdef14a.htm |
| 2026-04-07 | PRE 14A | formpre14a.htm |
| 2026-03-26 | 8-K | form8-k.htm |
| 2026-03-26 | 10-K | form10-k.htm |
| 2026-02-25 | 8-K | form8-k.htm |
| 2026-02-03 | 8-K | form8-k.htm |
| 2026-01-27 | CORRESP | filename1.htm |
| 2026-01-22 | S-3 | forms-3.htm |
| 2026-01-07 | D |